atai Life Sciences (ATAI) Misses Q4 EPS by 9c

atai Life Sciences (NASDAQ: ATAI) reported Q4 EPS of ($0.24), $0.09 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• Piper Sandler Downgrades Weave Communications Inc (WEAV) to Neutral
• Prenetics Global (PRE) Tops Q2 EPS by 18c